That is the test before you invest logic: fewer assumptions, a better conversation with your provider
This list compares their: Medication : Primary Use // Frequency // Starting Dose // Maximum Amount Ozempic: Type 2 Diabetes // Once Weekly // 0.25 mg // 2.0 mg Wegovy : Weight Loss // Once Weekly // 0.25 mg // 2.4 mg up to 7.2 mg* T irzepatide(Mounjaro / Zepbound): Diabetes & Weight Loss // Once Weekly // 2.5 mg // 15.0 mg Retatrutide (Phase 3 Trials): Weight Loss (Investigational) // Once Weekly // 2.0 mg // 12.0 mg Effectivness Comparing data from Retatrutide clinical trials shows it to be significantly more effective for weight loss when compared to previous GLP-1 medications
Fasting insulin, C-peptide, and HOMA2-IR fell by as much as 50 percent or more
The risk is not just about side effects, it is about what you do not build
Importantly, insulin resistance is not the same as blood glucose control
It's worth highlighting, though, that poorly controlled diabetes itself elevates the risk of gastroparesis
